The largest database of trusted experimental protocols

Ptrchis2b

Manufactured by Thermo Fisher Scientific

The PTrcHis2B is a plasmid vector designed for the expression of recombinant proteins in Escherichia coli. It features a trc promoter, a strong hybrid promoter derived from the trp and lac promoters, and a polyhistidine (His) tag sequence for affinity purification of the expressed proteins.

Automatically generated - may contain errors

5 protocols using ptrchis2b

1

Engineered E. coli for Sabinene Synthesis

Check if the same lab product or an alternative is used in the 5 most similar protocols
As mentioned above, E. coli BL21(DE3) has its native MEP pathway to form IPP and DMAPP. Therefore, the MEP pathway for sabinene synthesis was constructed by harboring the plasmid pHB1 to introduce the exogenous sabinene synthase. Furthermore, to enhance the metabolic flux into GPP by catalyzing the conversion of DMAPP and IPP, the GPP synthase (IspA or GPPS2) was overexpressed or introduced.
E. coli BL21(DE3) harboring pHB7 and pTrcLower was constructed to form the MVA pathway for sabinene synthesis. The mvaE (Genbank: AF290092) was amplified with the primer mvaE-F and mvaE-R from genomic DNA of Enterococcus faecalis (ATCC 700802D-5) and then cloned into pHB5 and with restriction enzymes Nco I and Bam HI, creating pHB6. The mvaS (Genbank: AF290092) was amplified from genomic DNA of E. faecalis (ATCC 700802D-5) with the primer mvaS-F and mvaS-R and cloned into pHB6 and with restriction enzymes Sac I and Pst I, creating pHB7. The ERG12, ERG8, ERG19 and IDI1 genes from S. cerevisiae (ATCC 204508) were cloned into pTrcHis2B (Invitrogen, Carlsbad, CA) using a method of successive hybridization to yield pTrcLower
[42 (link)].
+ Open protocol
+ Expand
2

Cloning and Characterization of Trc Promoter Library

Check if the same lab product or an alternative is used in the 5 most similar protocols
All primers and plasmids used in this study are listed in Table1. E. coli DH10B (Promega, Beijing, China) was used for plasmid construction, promoter library construction, and characterization. E. coli BL21(DE3) was used for peptide expression. Plasmid pTrcHis2B (Invitrogen, Shanghai, People's Republic of China) harboring trc promoter and its mutated promoter library was constructed and preserved in our laboratory. PrimeStar DNA polymerase, restriction endonucleases, T4 DNA ligase, and protein ladder were purchased from Takara Biotechnology (Dalian, People's Republic of China). Plasmid DNA isolation and DNA gel purification were performed using AxyPrep Plasmid Miniprep and AxyPrep DNA gel extraction kits (Axygen Biosciences, Union City, USA). DNA primers, bovine serum albumin (BSA), and all other regents were provided by Sangon Biotech (Shanghai, People's Republic of China). The working concentration of ampicillin was 100 mg L−1.
+ Open protocol
+ Expand
3

Cloning and Expression of Polyphosphate Kinase 2

Check if the same lab product or an alternative is used in the 5 most similar protocols
The P. aeruginosa gene PA2428 encoding PPK2 was codon-optimized for expression in E. coli and purchased from Thermo Fisher Scientific GeneArt. It was received in the expression plasmid pET100/D-TOPO and named pAU005. The gene is expressed under control of T7 promoter with an N-terminal His-tag, X-press epitope and EK-recognition site for tag cleavage. The glk gene encoding E. coli glucokinase (EGlk) was PCR amplified from genomic DNA of E. coli (strain K12) using the oligonucleotides EGlk-Forward (5′-AT ACCATGGGTACAAAGTATGCATTAGTCGG-3′) and EGlk-Reverse (5′-AGACCTTAGGTCACATTCTGGGTTCTGGACAT CATCACCATCATCACTAAGAATTCATA-3′). The forward primer introduced a NcoI site and an extra codon for glycine at the 5′-end of the coding sequence of EGlk. The reverse primer appended a Gly-Ser-Gly linker and a 6x His tag, stop codon and EcoRI restriction site near the 3′-end. The purified PCR fragment was cloned into NcoI and EcoRI sites of vector pTrcHis2B (Invitrogen) generating plasmid pAU007. EGlk is expressed under control of Trc promoter. The construct was verified by DNA sequencing. Plasmids were transformed into E. coli BL21 (DE3) strain and transformants were selected from LB agar plates containing 100 mg/L of ampicillin.
+ Open protocol
+ Expand
4

Cloning and Complementation of Pic Gene

Check if the same lab product or an alternative is used in the 5 most similar protocols
The pic gene was amplified from genomic DNA from EAEC 042 using the following oligonucleotides: Fw 5’- CCG CTC GAG CAT GAA TAA AGT TTA TTC TCT TAA ATA TTG CC -3’ and Rv 5’- CCG GAA TTC TCA GAA CAT ATA CCG GAA ATT CGC GTT -3’. The PCR product of 4,110 bp was purified using the QIAquick Gel Extraction Kit (Qiagen, Hilden, Germany) and digested with Xho1 and EcoR1 enzymes, and cloned in the inducible vector pTrcHis2B (Thermo Fisher Scientific, Rockford, IL). For the complementation, EAECΔpic bacteria were transformed with plasmid pTrcHis2B/pic to obtain the construction EAECΔpic/pPic. In posterior experiments, EAECΔpic/pPic was induced with 1 mM IPTG.
+ Open protocol
+ Expand
5

Cloning and expression of EPEC espF gene

Check if the same lab product or an alternative is used in the 5 most similar protocols
The espF gene was amplified from genomic DNA of the prototypical strains EPEC E2348/69 using the primers C‐Fwr‐espF (5′‐ATG CTT AAT GGA ATT AGT AAC GCT GCT‐3′) and C‐Rev‐espF (5′‐CTC GAG CCC TTT CTT CGA TTG CTC ATA GGC‐3′). The PCR product, espFEPEC (621 bp), was purified with QIAquick Gel Extraction Kit (Qiagen, Inc.) and cloned into pGEM‐T Easy vector (Promega Corp.) according to the manufacturer's instructions to create pGEMT‐espFEPEC. Subsequently, pGEMT‐espFEPEC was digested with NcoI/XhoI and subcloned into the IPTG inducible vector pTrcHis2B (Thermo Fisher Scientific) to obtain the polyhistidine‐tagged espF fusion construction, pTrc‐espFEPECHis. For espF complementation, EPECΔespF bacteria were transformed with pTrc‐espFEPECHis construction for subsequent infection assays.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!